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Abstract 
Background: Ovarian cancer is the most lethal gynecologic malignancy and it represents third most common malig-
nancy in Karachi (after breast and oral cancer). Due to lack of well established cancer registry in our country, changing 
trends of ovarian tumors has not been determined. Therefore we aimed to establish the current trends and classifica-
tion of ovarian tumors in our setup according to latest WHO guidelines.
Methods: We retrospectively analyzed 162 cases of ovarian tumors that underwent surgical resection from Janu-
ary 2009 till December 2014. Specimens were received in histopathology department, Liaquat National hospital 
and cases were examined by senior histopathologists and classified according to latest WHO guidelines. Various 
histopathologic parameters including capsular invasion, omental and lymph node meatstasis along with uterine and 
fallopian tube involvement were determined apart from tumor type and grade.
Results: Mean age at diagnosis was 35.8 years (± 15.5). surface epithelial tumors were most common, 109 cases 
(67.2 %) followed by germ cell tumors, 44 cases (27.1 %) and sex cord stromal tumors, 8 cases (4.9 %). Serous tumors 
were most common surface epithelial tumors with 90 % benign morphology. On the other hand, mucinous tumors 
showed a higher percentage of borderline and malignant features (16.7 and 14.6 % respectively). Higher incidence of 
capsular invasion and omental metastasis was noted in endometroid and serous carcinoma compared to mucinous 
tumors.
Conclusions: We noted a higher frequency of young age ovarian cancers in our set up. Serous and endometroid 
carcinomas were found to be associated with adverse prognostic factors like capsular invasion and omental metasta-
sis. Moreover a significantly higher proportion of ovarian tumors constitute mucinous histology including borderline 
tumors. Whether this represents a changing trend towards biology of these tumors in this part of the world needs to 
be uncovered by further studies.
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Background
Ovarian cancer is the most lethal gynecologic malignancy 
and owing to lack of early symptoms and screening pro-
tocol, it is detected late in the clinical course of the dis-
ease. The worldwide incidence rate is 6.3/100,000 women 
and is the seventh most common cancer diagnosis. 
Ovarian cancer is the third most malignancy in Karachi 
(after breast and oral cancer) with an age standardized 
incidence rate of 10.9 % [1]. The high incidence of ovarian 
cancer in this part of the world may be due to uncovered 
BRCA mutations in our population, but this is yet to be 
fully determined.
One of the unique characteristics of ovarian tumors 
are their capacity to undergo peritoneal metastasis in 
the absence of invasive growth in the ovary [13]. This 
has led to the concept of borderline tumors with a strict 
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histologic criteria not influenced by its metastatic coun-
terpart in the peritoneum. Due to lack of well estab-
lished cancer registry in our country, changing trends of 
ovarian tumors has not been determined. Therefore we 
aimed to establish the current trends and classification 
of ovarian tumors in our setup according to latest WHO 
guidelines.
Methods
We retrospectively analyzed 162 cases of ovarian tumors 
that underwent surgical resection from January 2009 
till December 2014. During this period of time, all cases 
with a provisional diagnosis of ovarian tumors requiring 
surgical treatment were included in the study. Out of the 
162 cases included in the study, 35 had a provisional or 
frozen section diagnosis of malignancy and thus under-
went bilateral oophorectomy along with total abdominal 
hysterectomy and omental, pelvic lymph nodes sam-
pling. On the other hand, 127 cases were benign and 
thus underwent oophorectomy only. All specimens were 
received in histopathology department, Liaquat National 
hospital. After gross examination, representative sec-
tions were stained with hematoxylin and eosin stains. 
Immunohistochemical stains were applied when neces-
sary. Cases were examined by senior histopathologists 
and classified according latest WHO guidelines. Various 
histopathologic parameters including capsular invasion, 
omental and lymph node metastasis along with uterine 
and fallopian tube involvement were determined apart 
from tumor type and grade.
Results
Mean age at diagnosis was 35.8  years (±  15.5). Surface 
epithelial tumors were most common, 109 cases (67.2 %) 
followed by germ cell tumors, 44 cases (27.1 %) and sex 
cord stromal tumors, 8 cases (4.9  %). Serous tumors 
were most common surface epithelial tumors with 90 % 
benign morphology. On the other hand mucinous tumors 
showed a higher percentage of borderline and malignant 
features (16.7 and 14.6  % respectively). Malignant sur-
face epithelial tumors were significantly seen to be more 
common in older age group compared to their benign 
and borderline counterparts (Table 1). Malignant surface 
epithelial tumors also tend to had larger sizes compared 
to benign and borderline cases (Table 2). Table 3 shows 
various histopathologic parameters of ovarian tumors. 
Higher incidence of capsular invasion and omental 
metastasis was noted in endometroid and serous carci-
noma compared to mucinous tumors. On the other hand, 
high frequency of ovarian capsular involvement was seen 
in malignant germ cell tumors and fibrosarcoma. Uterine 
and cervical involvement was also noted in a subset of 
serous and mucinous carcinomas.
Discussion
Ovarian cancers are the most common malignancies 
of the female genital tract and the 6th leading cancer in 
USA. It is estimated that the lifetime risk of developing 
an ovarian cancer among females is 1 in 70 [1]. Ovar-
ian carcinomas are a heterogeneous group of neoplasms 
showing diverse morphological characteristics, mecha-
nisms of pathogenesis and clinical features [2]. According 
to morphological features, ovarian tumors are classified 
as surface epithelial tumors, germ cell tumors, sex cord 
stromal tumors and metastatic tumors. The mean age of 
patients with these tumors is 63  years with 80  % of the 
tumors occurring after 45 years of age [3]. However our 
Table 1 Age distribution of ovarian tumors
Age groups
<20 years 20–40 years 40–60 years >60 years
n (%) n (%) n (%) n (%)
Surface epithelial tumor
 Benign 14 (17.1) 44 (53.7) 18 (22) 6 (7.3)
 Borderline 2 (25.0) 4 (50) 2 (25) 0 (0)
 Malignant 0 (0) 7 (38.9) 4 (22.2) 7 (38.9)
Germ cell tumor
 Benign 3 (8.1) 27 (73.0) 5 (13.5) 2 (5.4)
 Malignant 4 (66.7) 2 (33.3) 0 (0) 0 (0)
Sex cord stromal tumor
 Benign 1 (14.3) 3 (42.9) 0 (0) 3 (42.9)
 Malignant 0 (0) 1 (100.0) 0 (0) 0 (0)
Metastatic tumor
 Malignant 0 (0) 0 (0) 1 (100) 0 (0)
Table 2 Tumor size distribution of ovarian neoplasms
Tumor size Tumor size category
Mean <5 cm 5–10 cm 10–20 cm >20 cm
n (%) n (%) n (%) n (%)
Surface epithelial tumor
 Benign 10.31 15 (18.3) 36 (43.9) 27 (32.9) 4 (4.9)
 Borderline 19.56 0 (0) 0 (0) 6 (66.7) 3 (33.3)
 Malignant 19.08 1 (5.6) 3 (16.7) 6 (33.3) 8 (44.4)
Germ cell tumor
 Benign 10.41 4 (10.5) 19 (50) 13 (34.2) 2 (5.3)
 Malignant 14.15 1 (16.7) 0 (0) 4 (66.7) 1 (16.7)
Sex cord stromal tumor
 Benign 15.07 0 (0) 2 (28.6) 4 (57.1) 1 (14.3)
 Malignant 23.0 0 (0) 0 (0) 0 (0) 1 (100.0)
Secondary malignancy
 Malignant 6.0 0 (0) 1 (100) 0 (0) 0 (0)
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study shows that the mean age of tumors has significantly 
lower and more cases of ovarian tumors were seen in 
females at comparatively younger ages. Approximately 
40 % of malignant surface epithelial ovarian tumors were 
found in an age group of 20–40 years. Due to lack of can-
cer registries in our country, the demographics of ovarian 
cancer are poorly understood. Various studies conducted 
in our population revealed a lower age group distribution 
of breast cancer in this part of the world due to probable 
BRCA mutations may play a role in young age ovarian 
cancer as well [4]. Liaquat National Hospital is one of the 
largest tertiary care centre of the province and represents 
both rural and urban patient population of all age groups, 
therefore lower age distribution of ovarian cancer in our 
study don’t represent hospital demographics.
The distribution of these tumors shows variations in 
the incidence globally. Surface epithelial tumors were 
found to be the most common ovarian tumors. The inci-
dence of these tumors in our study (67.2 %) is comparable 
to a previous study done in the same region [5]. However 
studies done from other areas of Pakistan have shown 
slight variation in the incidence of these tumors. The fre-
quency of surface epithelial tumors from Punjab province 
was found to be 57  % [6] and KPK province was found 
to be 76.5  % respectively [7]. Surface epithelial tumors 
were followed by germ cell tumors and sex cord stromal 
tumors. The frequency of these tumors was found to be 
27 and 4.9 % respectively in our study comparable to the 
literature from other parts of the country [6, 7].
In our study majority of these tumors were benign and 
only a few cases of borderline and malignant category 
were found. The most common tumors were benign 
serous tumors accounting for 90  % of the serous sur-
face epithelial tumors and 44.9 % of all surface epithelial 
tumors, mostly presenting in females of the reproductive 
age group. However our study is almost consistent with 
the findings of study done by Ghartimagar et  al. which 
showed an incidence of benign serous surface epithelial 
tumors 49.4 % among of all surface epithelial tumors [8].
Benign serous tumors were followed by mucinous and 
endometroid tumors. It was noted that although major-
ity of mucinous tumors were benign there was a higher 
incidence of mucinous tumors of the borderline cate-
gory. Literature shows that the majority of the mucinous 
tumors are benign, 20 % borderline and 5 % invasive [9]. 
A recent review by J. Prat showed similar results indicat-
ing that majority of mucinous tumors i.e., 80 % are benign 
remainder are borderline and 3–4 % of the tumors being 
malignant [10]. On the other hand, our study showed 
similar results for the benign and borderline categories 
but there was a higher incidence of invasive mucinous 
neoplasms, 14.6  % compared to 5  % cited in literature. 
This shows that the incidence of invasive mucinous 
tumors is much higher in our population as compared to 
literature from the west.
Germ cell tumors comprised of 27  % of all the ovar-
ian neoplasms in our study. Of which majority of these 
tumors (86  %) were mature teratomas whereas rests of 
the tumors were malignant germ cell neoplasms. This 
proportion of germ cell tumors corresponded to the 
results of a study done in India by Mondal et  al. how-
ever the similar study showed a slightly higher numbers 

















n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Borderline
 Serous tumours 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
 Mucinous 
tumours
0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Malignant
 Serous tumours 2 (50) 1 (25) 1 (25) 1 (25) 0 (0) 0 (0) 1 (25)
 Mucinous 
tumours
1 (14.3) 2 (28.6) 1 (14.3) 1 (14.3) 1 (14.3) 0 (0) 1 (14.3)
 Endometrioid 
carcinoma
3 (75) 2 (40) 0 (0) 1 (20) 0 (0) 0 (0) 3 (60)
 Transitional cell 
car
0 (0) 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
 Dysgerminoma 1 (50) 1 (50) 0 (0) 1 (50) 1 (50) 0 (0) 0 (0)
 Yolk sac tumor 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
 Fibrosarcoma 1 (100) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
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of other germ cell tumors which were not present in our 
study [11].
Sex cord stromal tumors accounted for 4.9  % of all 
ovarian neoplasms and majority of tumors comprised 
of benign tumors. The incidence of these tumors corre-
sponds with literature as being the least common sub-
type of ovarian tumors [12, 13]. The main limitation of 
this study is that it is a single center experience and thus 
referral bias may be a limiting factor.
Conclusions
We found a higher frequency of young age ovarian can-
cers in our setup. Serous and endometroid carcinomas 
were found to be associated with adverse prognostic 
factors like capsular invasion and omental metastasis. 
Moreover a significantly higher proportion of ovarian 
tumors constitute mucinous histology including border-
line tumors. Whether this represents a changing trend 
towards biology of these tumors in this part of the world 
needs to be uncovered by further studies.
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